Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    NIAID | Open Studies | Hepatitis C
Show Display Options
RSS Create an RSS feed from your search for:
NIAID | Open Studies | Hepatitis C
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT);   Drug: Dasabuvir (DSV);   Drug: Ribavirin (RBV)
2 Recruiting 12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
Conditions: HIV-1 Infection;   Hepatitis C
Interventions: Drug: Ledipasvir/sofosbuvir;   Drug: Ribavirin
3 Recruiting Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
Conditions: Hepatitis;   HIV;   Liver Cancer
Intervention:
4 Recruiting Effects of Persistent Innate Immune Activation on Vaccine Efficacy
Condition: Hepatitis C Infection
Intervention: Drug: Recombivax
5 Recruiting Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination
Condition: Hepatitis C
Intervention: Drug: Zoster vaccine live
6 Recruiting Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Conditions: HIV-1 Infection;   Hepatitis
Interventions: Drug: Ribavirin;   Drug: Sofosbuvir;   Drug: Ledipasvir/Sofosbuvir
7 Recruiting Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre or Post Liver Transplant
Conditions: HIV;   Hepatitis C;   Cirrhosis
Intervention: Drug: Harvoni

Study has passed its completion date and status has not been verified in more than two years.